SEC Filing Summary: Zapata Corporation (10-Q)
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 31, 1999 for Zapata Corporation. The filing reflects a change in the company's fiscal year-end from September 30 to December 31, effective January 1, 1999. Zapata is a holding company primarily owning approximately 61% of Omega Protein Corporation (marine protein products) and 40% of Viskase Corporation (food packaging). The company also operates internet-based magazines and its subsidiary ZAP.COM. As of May 12, 1999, there were 23,887,078 shares of common stock outstanding.
Key Financial Metrics
| Metric (in thousands) | Q1 1999 | Q1 1998 |
|---|---|---|
| Revenues | $22,162 | $30,041 |
| Operating Income | $2,631 | $9,179 |
| Net (Loss) Income | $(612) | $6,470 |
| EPS (Basic) | $(0.03) | $0.28 |
| Cash and Cash Equivalents | $150,307 | $28,047 |
| Working Capital | $192,162 | N/A |
| Total Debt (Current + Long-term) | $11,897 | N/A |
| Net Cash from Operating Activities | $2,939 | $10,121 |
Note: Q1 1998 data is presented for the three months ended March 31, 1998, prior to the fiscal year change.
Material Changes vs. Prior Period
- Revenue Decline: Revenues decreased 26.3% to $22.2 million, driven entirely by Omega Protein. This was due to a 39% drop in crude fish oil sales volumes (deferred due to low prices) and a 12.9% decrease in fish meal selling prices.
- Net Loss: The company reported a net loss of $612,000 compared to net income of $6.47 million in the prior year. The loss was primarily caused by Omega Protein's reduced profitability and a $3.388 million "Other expense" charge related to a legal contingency.
- Legal Contingency: A significant non-operating expense of $3.388 million was recorded due to a court judgment against Zapata in a lawsuit brought by a former employee regarding stock options. The company has accrued this amount and plans to appeal.
- Viskase Investment: Zapata recorded no equity income from its 40% stake in Viskase. The equity method was suspended in the prior transition period due to Viskase's massive restructuring losses, and Zapata will not resume recording earnings until Viskase's future income offsets unrecognized losses.
- Liquidity: Cash balances remained strong at $150.3 million, down slightly from $154.7 million at year-end, primarily due to Omega Protein's capital expenditures and stock repurchases.
Guidance, Outlook, and Risks
- ZAP.COM Rights Offering: Zapata's subsidiary, ZAP.COM, filed for a rights offering to raise up to $108.9 million. Zapata intends to invest $8 million in ZAP.COM. Completion is expected in the third quarter of fiscal 1999, though no assurance is given.
- Future Expenses: Management anticipates significant operating expenses for the remainder of 1999 and 2000 related to the consolidation of ZAP.COM and internet initiatives.
- Legal Risks:
- Securities Class Action: 20 consolidated lawsuits allege false statements regarding internet acquisitions. The company intends to defend vigorously.
- Employee Litigation: A $3.45 million judgment was entered against Zapata; the company is appealing.
- Settlements: The "Holt Case" was settled in March 1999 (terms confidential), and the "Harwin/Crandon Case" was dismissed without prejudice.
- Year 2000 (Y2K): Zapata and Omega Protein are assessing Y2K compliance. Current systems are compliant, but risks remain regarding third-party vendors and service providers. No material costs are expected, but a contingency plan is not yet fully developed.
- Capital Resources: Zapata believes existing cash is sufficient to meet requirements through 2000. Omega Protein expects to finance future needs through operations and existing credit facilities.
Investor Verification Checklist
- Verify the status and potential outcome of the $3.45 million employee stock option lawsuit appeal.
- Monitor the progress and final terms of the ZAP.COM rights offering and the $8 million investment commitment.
- Track the resolution of the consolidated securities class action litigation regarding internet acquisitions.
- Assess the impact of commodity price fluctuations on Omega Protein's future revenue and margins.
- Confirm the timeline for resuming equity income recognition from Viskase Corporation.